Documento PDF Articolo scientifico Diego Miceli Stijn J M Niessen Juan P Rey Amunategui Florian K Zeugswetter (Clinical Centre for Small Animal Health and Research, Clinical Department for Small Animals and Horses, Departments, University of Veterinary Medicine Vienna) Gustavo Pompili Flavia Tavares Estela Molina Rodolfo Leal Ignacio Espiñeira Doroteia Bota Andrea Corsini Federico Fracassi Oxford University Press © The Author(s) 2026 open access 2026 doi:10.1093/jvimsj/aalaf050 Journal of Veterinary Internal Medicine Text journal article Text Wissenschaftlicher Artikel Open Access eng Hypersomatotropism without concurrent diabetes mellitus in cats: 28 cases (2014-2024) Background Hypersomatotropism (HST) in cats has predominantly been associated with diabetes mellitus (DM) and HST in nondiabetic cats is poorly described. Hypothesis/Objectives To describe the clinical presentation, clinicopathologic findings, and outcome of nondiabetic cats with presumed HST. Animals Twenty-eight client-owned cats. Methods Multi-site retrospective study based on medical records of nondiabetic cats seen at 10 institutions between 2014 and 2024 with presumed HST (elevated serum insulin-like growth factor-1 [IGF-1] ± clinical signs compatible with acromegaly ± documented pituitary enlargement). Clinical presentation, diagnostic findings, and survival times were reviewed. Results Twenty-eight cats with HST were included. Twenty-six cats were males, and 2 cats were females; mean age was 9.5 years (±SD 3.5 years); mean body weight was 7.1 kg (±SD 2.1 kg). The median serum IGF-1 concentration was 1236 ng/mL (range 704-2455 ng/mL). Nineteen of 28 cats (68%) had clinical signs possibly related to acromegaly: prognathia inferior (13/28), weight gain (12/28), broad facial features (10/28), abdominal enlargement (10/28), respiratory stridor (9/28), polyphagia (9/28), and signs of neurological disease (3/28). The most common clinicopathological abnormalities were hyperproteinemia (12/28), serum creatinine above the reference interval (RI) (10/28), and urinary specific gravity below the RI (9/28). Hypertrophic cardiomyopathy phenotype was identified in 8/17 cases. The most common comorbidity was chronic kidney disease (10/28). The median survival time after diagnosis was 24 months (range 1-103 months). Conclusions and clinical importance Hypersomatotropism can present without DM and should be considered in cats with signs suggestive of growth hormone excess or a pituitary tumor. Acromegaly Cats GH Excess Nondiabetic http://creativecommons.org/licenses/by-nc/4.0/ application/pdf https://phaidra.vetmeduni.ac.at/o:5409